Effect of Increased Convective Clearance by On-Line Hemodiafiltration on All Cause Mortality in Chronic Hemodialysis Patients

NCT00205556 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 715

Last updated 2011-01-21

No results posted yet for this study

Summary

The purpose of this study is to compare the effect of low flux hemodialysis with online hemodiafiltration on all cause mortality and a combination of cardiovascular morbidity and mortality in chronic hemodialysis patients.

Conditions

Interventions

PROCEDURE

on-line hemodiafiltration

addition of convective transport to regular dialysis treatment by using on-line hemodiafiltration

PROCEDURE

low flux hemodialysis

standard treatment

Sponsors & Collaborators

  • UMC Utrecht

    collaborator OTHER
  • Medical Center Alkmaar

    collaborator OTHER
  • Maasstad Hospital

    collaborator OTHER
  • Julius Center for Health Sciences and Primary Care, Utrecht

    collaborator UNKNOWN
  • Dutch Kidney Foundation

    collaborator OTHER
  • Fresenius Medical Care North America

    collaborator INDUSTRY
  • Gambro Renal Products, Inc.

    collaborator INDUSTRY
  • Baxter Healthcare Corporation

    collaborator INDUSTRY
  • Roche Pharma AG

    collaborator INDUSTRY
  • Amsterdam UMC, location VUmc

    lead OTHER

Principal Investigators

  • Menso J Nubé, MD PhD · Medical Center Alkmaar

  • Piet M ter Wee, MD PhD · Vrije Universiteit Medical Center, Amsterdam

  • Peter J Blankestijn, MD PhD · Universityr Medical Center Utrecht

  • René A van den Dorpel, MD PhD · Medisch Centrum Rijnmond Zuid - locatie Clara, Rotterdam

  • Michiel L Bots, MD PhD · Julius Center for Health Sciences and Primary Care, Utrecht

  • Muriel PC Grooteman, MD PhD · Vrije Universiteit Medical Center, Amsterdam

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-06-30
Primary Completion
2010-12-31
Completion
2011-01-31

Countries

  • Canada
  • Netherlands
  • Norway

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00205556 on ClinicalTrials.gov